JVJulia Vent

Julia Vent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julia Vent has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection

    by Moritz F. Meyer, Christian U. Huebbers, Oliver G. Siefer, Julia Vent, Iris Engbert, Guy D. Eslick, Markus Valter, Jens Peter Klussmann, Simon F. Preuss


  • OP128

    by Jos Straetmans, Julia Vent, Martin Lacko, Ernst-Jan Speel, Christian Huebbers, Robert Semrau, Frank Hoebers, Zlatan Mujagic, Jens-Peter Klussmann, Simon Preuss, et al.


  • p16 Expression in carcinoma of unknown primary: Diagnostic indicator and prognostic marker

    by Julia Vent, Bastian Haidle, Inga Wedemeyer, Christian Huebbers, Oliver Siefer, Robert Semrau, Simon F. Preuss, Jens Klussmann

    Background Carcinoma of unknown primary (CUP) of the neck are heterogeneous tumors in their clinical and biological characteristics, and a preoperative prognostic marker is desirable to optimize staging and therapy and to improve outcome and survival. For CUP syndrome, no optimized diagnostic and treatment strategy or biomarker have yet been determined. Methods Forty-seven patients presenting with CUP syndrome were analyzed after thorough standard diagnostic staging procedures. All patients were surgically treated with tonsillectomy, neck dissection of the diseased neck, as well as adjuvant chemoradiation. The tissue of lymph node metastases (and, if found, of the primary tumor) was analyzed regarding expression of p16, epidermal growth factor receptor (EGFR), and presence of human papillomavirus (HPV) DNA. Results In 39% of all cases (20 of 47), the primary cancer was found during diagnostic workup. If HPV DNA was detected in the neck lymph node metastasis, the primary cancer was significantly more frequently found in the oropharynx (p = .002). Patients with a p16-positive tumor had a significantly higher 5-year overall survival (OS; 33% vs 69%; p = .045, disease-free survival [DSF] 77% vs 89%; p = not significant [NS]). Patients with p16-positive neck metastasis and no detectable primary cancer had a better prognosis. Expression of EGFR in this series did not have a significant effect on prognosis. Conclusion In patients presenting with CUP syndrome, p16 immunohistochemistry can serve to locate the primary cancer in the oropharynx. It is a positive prognostic indicator in patients with those heterogeneous cancers. Head Neck, 35: 1521–1526, 2013


  • Effects of traditional Chinese acupuncture in post‐viral olfactory dysfunction

    by Julia Vent, Djin‐Wue Wang, Michael Damm

    Objective: To date, recovery of olfactory function after viral infection of the upper airway cannot be achieved reliably with pharmacotherapy. The aim of this study was to evaluate the effects of traditional Chinese acupuncture (TCA) on olfactory function in patients with persistent post‐viral olfactory dysfunction (PVOD).Study Design: Historical cohort study.Setting: University Medical Center, Department of Otorhinolaryngology.Subjects and Methods: A total of 15 patients presenting to the outpatient clinic with PVOD were treated by TCA in 10 weekly, 30‐minute sessions. Subjective olfactometry was performed with the Sniffin' Sticks test set. Treatment success was defined as an increase in Sniffin' Sticks test scores of at least six points. The effects of TCA, obtained with the χ2 test, were compared with those of matched pairs suffering from PVOD who had been treated with vitamin B complex over 12 weeks.Results: Eight patients treated with TCA had improved olfactory function compared with two treated with vitamin B complex. χ2 test revealed a significantly better outcome in olfactory function in patients undergoing acupuncture compared with patients receiving vitamin B complex (P = 0.02).Conclusion: TCA possibly offers a new therapeutic regimen for post‐viral dysosmia. More research in a larger case series is needed before a clearer picture will emerge.


  • Impact of recurrent head trauma on olfactory function in boxers: A matched pairs analysis

    by Julia Vent, Joerg Koenig, Martin Hellmich, Karl-Bernd Huettenbrink, Michael Damm


    • 1 December 2009
      • Vol. 27  (4) , 181-90

    Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.

    by Ralph Mösges, Walter Lehmacher, Norbert Pasch, Julia Vent

    The oral administration of fexofenadine 120 mg daily is a common treatment of seasonal allergic rhinitis (SAR). It reduces the H1 receptor-mediated symptoms, such as sneezing, pruritus, and nasal secretion as well as non-nasal symptoms such as conjunctivitis. The objective was to assess the effect of fexofenadine on nasal symptoms (such as nasal obstruction) in seasonal allergic rhinitis. A placebo-controlled, double-blind, randomized, cross-over study was performed which yielded evidence that two-week therapy with fexofenadine 120 mg daily in patients with SAR also relieves nasal obstruction and congestion. The parameters of nasal obstruction were evaluated by means of rhinoscopy, a subjective symptom score, and active anterior rhinomanometry. The subjective evaluation of nasal obstruction/congestion as recorded by the patient every 15 minutes for 4.5 hours after nasal allergen provocation showed a significant difference of the AUC (p = 0.025) between fexofenadine and placebo with a 12.8% lower obstruction after fexofenadine. The swelling of the nasal mucosa, which was assessed by rhinoscopy for 4.5 hours after nasal allergen provocation, was 21% lower after treatment with fexofenadine (p = 0.041). In this double-blind, placebo-controlled trial, subjective patient ratings as well as objective investigator assessments demonstrate the anti-obstructive effect of fexofenadine in nasal allergen challenge.


  • The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment

    by Julia Vent, Walter Lehmacher

    The assessment of pharmacological efficacy of rhinosinusitis and rhinoconjunctivitis has been performed in various studies involving standardized measures such as symptom scores, various health-related quality of life scales, the sino-nasal outcome test, or the rhinoconjunctivitis quality of life questionnaire. However, the methods and study designs are heterogeneous, and a methodological standard is still lacking. The aim of this review was--from a clinical and a methodological point of view--to evaluate placebo-controlled trials permitting the use of rescue medication and to provide insight into the specific challenges of such clinical trials. Using studies published within the past 24 months as examples, we here demonstrate the problems in evaluating and interpreting these studies and describe possibilities for refining the methodology in order to improve future study designs. The World Allergy Organization has recently published recommendations for the standardization of clinical trials on respiratory allergy in which methodological aspects regarding the use of rescue medication are discussed. This study summarizes the recommendations for study design, outcome measures, and statistical analysis to be used in planning, performing, and analyzing clinical studies on rhinoconjunctivitis and rhinosinusitis that allow the use of rescue medication.


  • Effects of short inter-stimulus intervals on olfactory and trigeminal event-related potentials

    by Ahmed Kassab, Friederike Schaub, Julia Vent, Karl-Bernd Huttenbrink, Michael Damm

  • Zervikales Neurofibrom als Ursache von Globusgefühl

    by J. Vent, G. Quante, E. Markert, J.P. Klussmann, D. Beutner

    Globusgefühl ist ein Symptom vielfältiger Ursachen, mit dem der Hals-Nasen-Ohren-Arzt oft konfrontiert wird. Wir berichten hier von einer 33 Jahre alten Frau, die sich mit seit 6 Monaten progredientem Globusgefühl vorstellte. Die HNO-ärztliche Untersuchung und eine Gastrographin-Breischluck-Untersuchung ergaben keine richtungweisenden Befunde. Erst die Schnittbildgebung zeigte eine Raumforderung links zervikal, welche nach Exzision die histopathologische Diagnose eines Neurofibroms ergab. Dieser Fall unterstreicht die Notwendigkeit apparativer Diagnostik in der Dysphagiediagnostik. A 33-year-old, otherwise healthy female nursing student presented to the ear-, nose-, and throat- (ENT) outpatient clinic with a globus sensation that had been progressing for 6 months. Tomographic imaging revealed a neck mass extending from the 4th vertebrum to the subclavicular region and apex of the left lung. A surgical resection with histopathological examination exposed a neurofibroma. Management and differential diagnoses of globus sensation are herein discussed. This case underlines the importance of tomographic imaging, even in common but persisting symptoms such as globus sensation.